Position in GILD
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$2,851,620
-$375,492 QoQ
Shares Held
22,571
-2.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.80%
of 13F equity value
Holder Rank
#729
of 2,266 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 20263Chopt Investment Partners, LLC holds $21,377,089 across 8 Drug Manufacturers - General names. GILD ranks #5 (13.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
21,776 | $5,530,450 | |
| 2 | LLY |
ELI LILLY & Co
|
4,014 | $4,814,512 | |
| 3 | ABBV |
AbbVie Inc.
|
14,191 | $3,571,023 | |
| 4 | MRK |
Merck & Co., Inc.
|
24,198 | $3,109,443 | |
| 5 | GILD |
Gilead Sciences, Inc.
This page
|
22,571 | $2,851,620 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
11,859 | $683,315 | |
| 7 | AMGN |
Amgen Inc
|
1,629 | $589,893 | |
| 8 | PFE |
Pfizer Inc
|
9,420 | $226,833 |
All Filings in GILD
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,851,620 | 22,571 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $3,227,112 | 23,155 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $2,893,227 | 23,572 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $2,623,596 | 23,636 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $2,457,100 | 22,162 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $2,111,470 | 18,844 | Shares | Sole | 2025-04-24 | |
| No filing history on record for this holder in this stock. | ||||||